CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-12 | Nashat Amir Director | Conversion · Series B Redeemable Convertible Preferred Stock | −34,737 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series B-2 Redeemable Convertible Preferred Stock | −4,168,683 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series B-2 Redeemable Convertible Preferred Stock | −81,248 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series B-2 Redeemable Convertible Preferred Stock | −28,556 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series B-2 Redeemable Convertible Preferred Stock | −41,686 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series C Redeemable Convertible Preferred Stock | −4,208,756 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series C Redeemable Convertible Preferred Stock | −82,029 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series C Redeemable Convertible Preferred Stock | −28,831 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series C Redeemable Convertible Preferred Stock | −42,087 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series D Redeemable Convertible Preferred Stock | −1,470,577 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series D Redeemable Convertible Preferred Stock | −28,661 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series D Redeemable Convertible Preferred Stock | −10,074 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series D Redeemable Convertible Preferred Stock | −14,706 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series E Redeemable Convertible Preferred Stock | −862,318 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series E Redeemable Convertible Preferred Stock | −16,806 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series E Redeemable Convertible Preferred Stock | −5,906 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series E Redeemable Convertible Preferred Stock | −8,623 | 0 | ||
| 2015-05-12 | Flynn James E 10% owner | Conversion | +230,764 | 230,764 | ||
| 2015-05-12 | Flynn James E 10% owner | Conversion | +230,764 | 230,764 | ||
| 2015-05-12 | Flynn James E 10% owner | Purchase | +25,000 | $14.00 | $350K | 255,764 |
Page 23 of 25 · 483 trades